- Home
- ALOT vs IMA Comparison
ALOT vs IMA Comparison
Compare ALOT & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALOT
- IMA
- Stock Information
- Founded
- ALOT 1969
- IMA 2019
- Country
- ALOT United States
- IMA United States
- Employees
- ALOT N/A
- IMA N/A
- Industry
- ALOT Computer peripheral equipment
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALOT Technology
- IMA Health Care
- Exchange
- ALOT Nasdaq
- IMA Nasdaq
- Market Cap
- ALOT 78.2M
- IMA 92.2M
- IPO Year
- ALOT N/A
- IMA N/A
- Fundamental
- Price
- ALOT $9.83
- IMA $8.60
- Analyst Decision
- ALOT
- IMA
- Analyst Count
- ALOT 0
- IMA 0
- Target Price
- ALOT N/A
- IMA N/A
- AVG Volume (30 Days)
- ALOT 28.9K
- IMA 75.0K
- Earning Date
- ALOT 09-09-2025
- IMA 11-15-2025
- Dividend Yield
- ALOT N/A
- IMA N/A
- EPS Growth
- ALOT N/A
- IMA N/A
- EPS
- ALOT N/A
- IMA N/A
- Revenue
- ALOT $151,593,000.00
- IMA $4,300,000.00
- Revenue This Year
- ALOT N/A
- IMA N/A
- Revenue Next Year
- ALOT N/A
- IMA N/A
- P/E Ratio
- ALOT N/A
- IMA N/A
- Revenue Growth
- ALOT 0.63
- IMA N/A
- 52 Week Low
- ALOT $7.53
- IMA $7.57
- 52 Week High
- ALOT $17.24
- IMA $23.28
- Technical
- Relative Strength Index (RSI)
- ALOT 39.67
- IMA N/A
- Support Level
- ALOT $9.88
- IMA N/A
- Resistance Level
- ALOT $10.48
- IMA N/A
- Average True Range (ATR)
- ALOT 0.34
- IMA 0.00
- MACD
- ALOT 0.02
- IMA 0.00
- Stochastic Oscillator
- ALOT 20.39
- IMA 0.00
About ALOT AstroNova Inc.
AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.
About IMA ImageneBio Inc. Common Stock
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.